Table 1 Demographic and lifestyle characteristics associated with treatment resistance among patients with PPD

From: Risk factors for treatment resistance among women with postpartum depression in a nationwide study

Variables

Non-TRPPD

TRPPD

RR (95% CI)b

(n = 55,096)

(n = 3,522)

AR (%)a

Model 1

Pc

Model 2

Pc

Maternal age, y

 <20

849 (1.5)

85 (2.4)

9.1

1.52 (1.22–1.90)

<0.001*

1.07 (0.85–1.36)

0.743

 20–24

6,962 (12.6)

575 (16.3)

7.6

1.27 (1.15–1.41)

<0.001*

1.10 (0.99–1.22)

0.145

 25–29

16,391 (29.7)

1,044 (29.6)

6.0

reference

 

reference

 

 30–34

18,577 (33.7)

1,061 (30.1)

5.4

0.90 (0.83–0.98)

0.032*

0.96 (0.88–1.04)

0.494

 35–39

9,925 (18.0)

605 (17.2)

5.7

0.96 (0.87–1.06)

0.546

1.01 (0.91–1.12)

0.931

 ≥40

2,392 (4.3)

152 (4.3)

6.0

1.00 (0.84–1.18)

0.984

1.01 (0.85–1.20)

0.941

Educational level, y

 >12

25,298 (45.9)

1,296 (36.8)

4.9

reference

 

reference

 

 9–12

21,788 (39.5)

1,454 (41.3)

6.3

1.28 (1.19–1.38)

<0.001*

1.24 (1.14–1.34)

<0.001*

 <9

6,921 (12.6)

651 (18.5)

8.6

1.76 (1.61–1.94)

<0.001*

1.61 (1.45–1.79)

<0.001*

 Unknown

1,089 (2.0)

121 (3.4)

10.0

NA

 

NA

 

Household income level

 Top 20%

10,068 (18.3)

489 (13.9)

4.6

reference

 

reference

 

 Middle

34,318 (62.3)

2,159 (61.3)

5.9

1.28 (1.16–1.41)

<0.001*

1.19 (1.07–1.31)

0.002*

 Lowest 20%

10,426 (18.9)

842 (23.9)

7.5

1.61 (1.44–1.80)

<0.001*

1.35 (1.20–1.52)

<0.001*

 Unknown

284 (0.5)

32 (0.9)

10.1

NA

 

NA

 

Civil status

 Cohabiting

50,636 (91.9)

3,103 (88.1)

5.8

reference

 

reference

 

 Non-cohabiting

4,460 (8.1)

419 (11.9)

8.6

1.49 (1.34–1.65)

<0.001*

1.27 (1.15–1.42)

<0.001*

Calendar year at delivery

 2006–2010

14,341 (26.0)

1,015 (28.8)

6.6

reference

 

reference

 

 2011–2015

17,074 (31.0)

1,153 (32.7)

6.3

0.95 (0.87–1.03)

0.220

0.97 (0.89–1.06)

0.536

 2016–2021

23,681 (43.0)

1,354 (38.4)

5.4

0.81 (0.74–0.88)

<0.001*

0.85 (0.78–0.93)

<0.001*

Maternal country of birth

 Sweden

45,795 (83.1)

2,809 (79.8)

5.8

reference

 

reference

 

 Europe

3,237 (5.9)

254 (7.2)

7.3

1.26 (1.11–1.43)

0.001*

1.25 (1.09–1.42)

0.003*

 Non-Europe

6,064 (11.0)

459 (13.0)

7.0

1.22 (1.10–1.34)

<0.001*

1.15 (1.04–1.28)

0.015*

Maternal residency in Sweden

 Southern

12,068 (21.9)

762 (21.6)

5.9

reference

 

reference

 

 Middle

33,948 (61.6)

2,082 (59.1)

5.8

0.97 (0.90–1.06)

0.621

1.00 (0.92–1.08)

0.955

 Northern

9,080 (16.5)

678 (19.3)

6.9

1.17 (1.05–1.30)

0.006*

1.17 (1.05–1.29)

0.008*

Body mass index in early pregnancy, kgm−2

 <18.5

1,254 (2.3)

98 (2.8)

7.2

1.25 (1.02–1.54)

0.050

1.16 (0.95–1.42)

0.288

 18.5–<25

27,918 (50.7)

1,713 (48.6)

5.8

reference

 

reference

 

 25–<30

13,719 (24.9)

869 (24.7)

6.0

1.03 (0.95–1.12)

0.592

1.01 (0.93–1.09)

0.941

 30–<40

7,676 (13.9)

539 (15.3)

6.6

1.13 (1.03–1.25)

0.019*

1.07 (0.97–1.18)

0.300

 ≥40

845 (1.5)

60 (1.7)

6.6

1.15 (0.89–1.48)

0.424

1.05 (0.81–1.36)

0.833

 Unknown

3,684 (6.7)

243 (6.9)

6.2

NA

 

NA

 

Smoking in early pregnancy

 No smoking

47,360 (86.0)

2,799 (79.5)

5.6

reference

 

reference

 

 1–9 cigarettes day−1

3,592 (6.5)

379 (10.8)

9.5

1.71 (1.54–1.90)

<0.001*

1.45 (1.30–1.63)

<0.001*

 ≥10 cigarettes day−1

1,168 (2.1)

132 (3.7)

10.2

1.82 (1.53–2.17)

<0.001*

1.53 (1.28–1.84)

<0.001*

 Unknown

2,976 (5.4)

212 (6.0)

6.6

NA

 

NA

 

Snus use in early pregnancy

 No

51,919 (94.2)

3,293 (93.5)

6.0

reference

 

reference

 

 Yes

12,01 (2.2)

92 (2.6)

7.1

0.84 (0.68–1.03)

0.154

0.91 (0.74–1.12)

0.562

 Unknown

1,976 (3.6)

137 (3.9)

6.5

NA

 

NA

 
  1. NA, not applicable.
  2. aAbsolute risk of TRPPD = (number of TRPPD/total number of patients with PPD in this category) × 100%.
  3. bModel 1: estimates from Poisson regression, univariate analysis without adjustment; Model 2: estimates from Poisson regression, adjusted for age, educational level, calendar year, residential region, maternal country of birth, parity and multiple gestation, if applicable.
  4. cP values were corrected for multiple testing using Benjamini-Hochberg method.
  5. *P < 0.05.